BACKGROUND: Transrectal ultrasound guided prostate needle biopsies are routinely performed to diagnose and stage prostate cancer. We prospectively evaluated the safety, morbidity, and complication rate. MATERIALS AND METHODS: We studied 336 patients who underwent transrectal ultrasound guided prostate needle biopsy. A post-biopsy questionnaire was sent to the patients 4 weeks after biopsy concerning questions about minor complications. Information on major complications was obtained by telephone interview. RESULTS: There were 2 major and 48 minor complications. The most common complication was hematuria in 6.5% of cases, followed by pain while urinating in 6.0% of cases. There was no statistically significance difference between hematuria and aspirin/thrombolytic drug use (P = 0.170) and between positive microbiology in urine and elevated temperature (P = 0.665). CONCLUSIONS: Transrectal ultrasound guided prostate needle biopsy is safe for diagnosing prostate cancer with few major and minor complications. Aspirin/thrombolytic drug use in patients' history is no risk factor for hematuria. Positive microbiology in urine before biopsy is no risk factor for a higher infection rate.
BACKGROUND: Transrectal ultrasound guided prostate needle biopsies are routinely performed to diagnose and stage prostate cancer. We prospectively evaluated the safety, morbidity, and complication rate. MATERIALS AND METHODS: We studied 336 patients who underwent transrectal ultrasound guided prostate needle biopsy. A post-biopsy questionnaire was sent to the patients 4 weeks after biopsy concerning questions about minor complications. Information on major complications was obtained by telephone interview. RESULTS: There were 2 major and 48 minor complications. The most common complication was hematuria in 6.5% of cases, followed by pain while urinating in 6.0% of cases. There was no statistically significance difference between hematuria and aspirin/thrombolytic drug use (P = 0.170) and between positive microbiology in urine and elevated temperature (P = 0.665). CONCLUSIONS: Transrectal ultrasound guided prostate needle biopsy is safe for diagnosing prostate cancer with few major and minor complications. Aspirin/thrombolytic drug use in patients' history is no risk factor for hematuria. Positive microbiology in urine before biopsy is no risk factor for a higher infection rate.
Authors: Bong Hee Park; Jung Im Kim; Sang Rak Bae; Yong Seok Lee; Sung Hak Kang; Chang Hee Han Journal: Int Urol Nephrol Date: 2017-05-04 Impact factor: 2.370
Authors: Suzanne van den Heuvel; Stacy Loeb; Xiaoye Zhu; Paul Cms Verhagen; Fritz H Schröder; Chris H Bangma; Monique J Roobol Journal: Am J Clin Exp Urol Date: 2013-12-25
Authors: Thorsten H Ecke; Steffen Hallmann; Stefan Koch; Jürgen Ruttloff; Henning Cammann; Holger Gerullis; Kurt Miller; Carsten Stephan Journal: ISRN Urol Date: 2012-07-05